{"id":"https://openalex.org/W2009449379","doi":"https://doi.org/10.1097/tp.0b013e31822a40d7","title":"Everolimus and Long-Term Outcomes in Renal Transplantation: Seeking an Optimal Strategy for Immunosuppression","display_name":"Everolimus and Long-Term Outcomes in Renal Transplantation: Seeking an Optimal Strategy for Immunosuppression","publication_year":2011,"publication_date":"2011-07-28","ids":{"openalex":"https://openalex.org/W2009449379","doi":"https://doi.org/10.1097/tp.0b013e31822a40d7","mag":"2009449379","pmid":"https://pubmed.ncbi.nlm.nih.gov/21799391"},"language":"en","primary_location":{"id":"doi:10.1097/tp.0b013e31822a40d7","doi":"https://doi.org/10.1097/tp.0b013e31822a40d7","is_oa":false,"landing_page_url":"https://doi.org/10.1097/tp.0b013e31822a40d7","pdf_url":null,"source":{"id":"https://openalex.org/S11564597","display_name":"Transplantation","issn_l":"0041-1337","issn":["0041-1337","1534-6080"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038938677","display_name":"Anthony P. Monaco","orcid":"https://orcid.org/0000-0001-7480-3197","observed_orcids":["https://orcid.org/0000-0001-7480-3197"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Anthony P. Monaco","raw_affiliation_strings":["Beth Israel/Deaconess Medical Center, Harvard Medical School, The Transplant Center, 110 Francis Street, Boston, MA 02215, USA. amonaco@bidmc.harvard.edu","Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel/Deaconess Medical Center, Harvard Medical School, The Transplant Center, 110 Francis Street, Boston, MA 02215, USA. amonaco@bidmc.harvard.edu","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5106234192","display_name":"Peter J. Morris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I14746517","display_name":"Royal College of Surgeons of England","ror":"https://ror.org/02qrg5a24","country_code":"GB","type":"funder","lineage":["https://openalex.org/I14746517"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210089966","display_name":"London School of Hygiene & Tropical Medicine","ror":"https://ror.org/00a0jsq62","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210089966"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Peter J. Morris","raw_affiliation_strings":["John Radcliffe Hospital, Headington, Oxford, United Kingdom; Centre for Evidence in Transplantation, Royal College of Surgeons of England and London School of Hygiene and Tropical Medicine, London, United Kingdom","Centre for Evidence in Transplantation, Royal College of Surgeons of England and London School of Hygiene and Tropical Medicine, London, United Kingdom","John Radcliffe Hospital, Headington, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Radcliffe Hospital, Headington, Oxford, United Kingdom; Centre for Evidence in Transplantation, Royal College of Surgeons of England and London School of Hygiene and Tropical Medicine, London, United Kingdom","institution_ids":["https://openalex.org/I14746517","https://openalex.org/I2802742124","https://openalex.org/I4210089966"]},{"raw_affiliation_string":"Centre for Evidence in Transplantation, Royal College of Surgeons of England and London School of Hygiene and Tropical Medicine, London, United Kingdom","institution_ids":["https://openalex.org/I14746517","https://openalex.org/I4210089966"]},{"raw_affiliation_string":"John Radcliffe Hospital, Headington, Oxford, United Kingdom","institution_ids":["https://openalex.org/I2802742124"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5038938677"],"corresponding_institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"],"apc_list":null,"apc_paid":null,"fwci":0.4786,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.65670672,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":96},"biblio":{"volume":"92","issue":"3S","first_page":"S1","last_page":"S2"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12900","display_name":"Organ and Tissue Transplantation Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.9990000128746033},{"id":"https://openalex.org/keywords/kidney-transplantation","display_name":"kidney transplantation","score":0.7850000262260437},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.7699999809265137},{"id":"https://openalex.org/keywords/calcineurin-inhibitor-minimization","display_name":"calcineurin inhibitor minimization","score":0.8700000047683716},{"id":"https://openalex.org/keywords/calcineurin-inhibitor-nephrotoxicity","display_name":"calcineurin inhibitor nephrotoxicity","score":0.8970000147819519},{"id":"https://openalex.org/keywords/chronic-allograft-nephropathy","display_name":"chronic allograft nephropathy","score":0.9710000157356262},{"id":"https://openalex.org/keywords/interstitial-fibrosis-and-tubular-atrophy","display_name":"interstitial fibrosis and tubular atrophy","score":0.9359999895095825},{"id":"https://openalex.org/keywords/acute-rejection","display_name":"acute rejection","score":0.7639999985694885},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.5580000281333923},{"id":"https://openalex.org/keywords/long-term-graft-survival","display_name":"long-term graft survival","score":0.6150000095367432},{"id":"https://openalex.org/keywords/antiproliferative-therapy","display_name":"antiproliferative therapy","score":0.550000011920929},{"id":"https://openalex.org/keywords/mycophenolate-mofetil","display_name":"mycophenolate mofetil","score":0.8109999895095825}],"concepts":[{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.9396445751190186},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.8925596475601196},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.6743276119232178},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6419085264205933},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5894611477851868},{"id":"https://openalex.org/C2780303639","wikidata":"https://www.wikidata.org/wiki/Q740909","display_name":"Kidney transplantation","level":3,"score":0.42832425236701965},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4216792583465576},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33381515741348267},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2994149923324585},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068338","descriptor_name":"Everolimus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006084","descriptor_name":"Graft Rejection","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016030","descriptor_name":"Kidney Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/tp.0b013e31822a40d7","doi":"https://doi.org/10.1097/tp.0b013e31822a40d7","is_oa":false,"landing_page_url":"https://doi.org/10.1097/tp.0b013e31822a40d7","pdf_url":null,"source":{"id":"https://openalex.org/S11564597","display_name":"Transplantation","issn_l":"0041-1337","issn":["0041-1337","1534-6080"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation","raw_type":"journal-article"},{"id":"pmid:21799391","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21799391","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation","raw_type":"Introductory Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7004411822","display_name":"Understanding the genetic basis of common human diseases: core funding for the Wellcome Trust Centre for Human Genetics.","funder_award_id":"090532","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"}],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W1989762934","https://openalex.org/W2093769049"],"related_works":["https://openalex.org/W2001808867","https://openalex.org/W2141211189","https://openalex.org/W2051464279","https://openalex.org/W2065272201","https://openalex.org/W2081387005","https://openalex.org/W1630708299","https://openalex.org/W2317908290","https://openalex.org/W3189215025","https://openalex.org/W1899338334","https://openalex.org/W2118915697"],"abstract_inverted_index":{"A":[0,194,659],"recent":[1],"colloquium/supplement":[2,64,1457,1529],"in":[3,116,127,226,332,487,543,574,612,708,810,831,862,923,949,986,1025,1143,1215,1245,1259,1356,1379,1435,1447,1490],"this":[4,165,683,822,1456,1528],"journal":[5],"that":[6,21,100,120,173,229,255,449,466,482,499,525,607,638,698,858,918,971,973,1002,1020,1159,1205,1221,1252,1455,1478,1527,1547,1566],"examined":[7,919],"the":[8,31,71,198,205,218,222,234,450,520,554,569,578,583,609,613,665,722,731,736,832,894,913,924,974,987,1003,1021,1031,1047,1069,1098,1108,1207,1248,1265,1276,1299,1317,1334,1345,1365,1400,1413,1469,1498,1505,1516,1548,1556,1559,1567,1586,1589],"problem":[9],"of":[10,46,74,102,171,178,197,221,247,266,290,308,334,355,363,414,418,423,430,472,512,523,556,561,587,604,622,676,680,701,705,725,751,772,812,834,897,912,921,951,978,1006,1023,1071,1100,1110,1115,1136,1191,1209,1267,1279,1304,1319,1336,1350,1367,1404,1417,1421,1429,1445,1452,1468,1508,1510,1558],"chronic":[11,22,33,40],"renal":[12,273,356,377,488,513,961,1175,1234,1260,1380],"allograft":[13,23,274,715,954],"damage":[14,1235],"and":[15,26,30,91,125,130,149,189,203,209,214,268,283,294,302,325,339,372,399,421,433,454,531,550,558,566,590,595,620,644,657,670,693,727,735,740,765,777,883,903,930,953,956,976,1041,1064,1102,1134,1151,1171,1241,1289,1298,1348,1364,1411,1432,1472,1500,1534,1588],"late":[16,470,1305],"graft":[17,34,309,321,351,357,864,1008],"loss":[18,35],"(1)":[19],"suggested":[20],"nephropathy/interstitial":[24],"fibrosis":[25],"tubular":[27],"atrophy":[28],"(CAN/IFTA)":[29],"associated":[32,297,406,435,747,769,958],"were":[36,981],"due":[37,360,369,411],"to":[38,59,69,84,163,182,185,201,350,361,370,396,412,459,479,491,500,507,615,775,845,1000,1033,1052,1077,1090,1138,1163,1228,1309,1354,1373,1440,1483,1493,1514,1545,1555,1574,1579],"ongoing":[39,215,1129,1250,1423,1473],"alloimmunity,":[41],"presumably":[42],"an":[43,536,1186,1199,1580],"unintended":[44],"consequence":[45],"reduced":[47,145,263,723,1408],"immunosuppression":[48,1296],"(IS)":[49],"caused":[50,344],"by":[51,264,345,392,664,1037,1087,1406,1412,1585],"aggressive":[52],"calcineurin":[53],"inhibitor":[54,76],"(CNI)":[55],"drug":[56,224],"elimination/minimization":[57],"strategies":[58,758,1084,1486],"avoid":[60],"CNI":[61,128,231,326,393,402,437,445,462,502,938,1027,1039,1080,1082,1105,1213,1230,1268,1271,1308,1323,1343,1352,1376,1409],"nephrotoxicity.":[62],"This":[63],"focuses":[65],"on":[66,217,494,721,928,1301],"current":[67,1130,1249],"efforts":[68],"use":[70,101,220,246,265,438,542,700,750,920,1022,1208],"mammalian":[72],"target":[73],"rapamycin":[75],"(mTORi)":[77],"everolimus":[78,115,135,225,455,562,623,656,702,872,922,936,984,1024,1078,1116,1139,1164,1195,1211,1222,1258,1274,1280,1310,1320,1340,1355,1370,1374,1446,1477,1488],"(Certican,":[79],"Novartis,":[80],"East":[81],"Hanover,":[82],"NJ)":[83],"achieve":[85],"safe,":[86],"effective":[87,944,1092,1200],"CNI-sparing":[88],"immunosuppressive":[89],"protocols":[90,228,1491],"hopefully":[92,190],"improve":[93,191,1034],"long-term":[94,192,272,1035,1178,1427,1495,1506],"outcomes.":[95,193,1496],"There":[96],"is":[97,330,381,390,404,577,642,768,787,940,957,1112,1224,1551],"strong":[98,441,457,538],"evidence":[99],"mTORi":[103,131,223,248,451,508,600,840,1396,1418],"drugs":[104,132,249,452,509,601],"could":[105,154,1479],"optimize":[106,186],"IS":[107,141,187,227,993,1093],"protocols:":[108],"more":[109,650,795],"than":[110,652,782,796,1361,1384],"6000":[111],"patients":[112,483,774,791,1192],"have":[113,121,136,261,807,820,1118,1543],"received":[114],"13":[117],"completed":[118,213],"trials":[119,216,819,857,890,917,970,1073,1131,1251,1263,1331,1425,1475,1512],"shown":[122],"equal":[123,1169],"efficacy":[124,208,1135,1266],"safety":[126,210,1133,1172,1278],"elimination/minimization,":[129],"such":[133,250],"as":[134,251,655,743,943,945],"important":[137,1459],"pleiotropic":[138,521],"effects":[139,522,739,896,1403,1416],"beyond":[140],"(anti-cardiovascular":[142],"disease":[143],"[CVD],":[144],"opportunistic":[146,528],"[viral]":[147],"infections,":[148,324,530,730],"antimalignancy":[150,733],"effects)":[151],"(2),":[152],"which":[153,167,389,575],"significantly":[155],"augment":[156],"their":[157,541],"value.":[158],"The":[159,427,618,963,1182,1450,1524,1541],"editors":[160,1451,1525,1542],"are":[161,624,661,671,1180,1332,1503,1518],"pleased":[162],"present":[164,996,1198],"colloquium/supplement,":[166],"summarizes":[168],"a":[169,176,382,440,626,647,835,909,1026,1225],"series":[170],"meetings":[172,199],"brought":[174],"together":[175],"group":[177],"European":[179],"transplant":[180,380,877,1381,1448],"experts":[181],"consider":[183],"ways":[184],"regimens":[188,1145],"major":[195,383],"objective":[196],"was":[200,873,1010,1530],"evaluate":[202],"summarize":[204,553,1244],"existing":[206,779,793],"clinical":[207,559,818,889,916,969,998,1072,1217,1424,1474],"data":[211,697,853,885,966,999,1482],"from":[212,854,886,967,1140,1161,1307,1375,1390,1537],"preemptive":[219,544,699,749,1210],"minimize/eliminate":[230],"use.":[232,785],"In":[233,1055],"introduction,":[235],"guest":[236],"editor":[237],"Josep":[238,1065],"M.":[239,1066],"Campistol":[240,447,1067],"discusses":[241,519],"possible":[242],"rationales":[243],"for":[244,279,305,313,386,443,540,673,759,790,983,1050,1189,1193,1257,1461,1487],"early":[245,710,1075,1120,1194,1351],"everolimus.":[252,752,898,1016],"He":[253,464],"notes":[254,465],"although":[256],"acute":[257],"rejection":[258],"(AR)":[259],"rates":[260],"been":[262,687,1572],"CNIs":[267,473,1089,1141,1162,1405],"mycophenolate":[269],"mofetil":[270],"(MMF),":[271],"survival":[275,955],"has":[276,685,1030,1570],"not":[277,686,788,1011,1552,1571],"improved":[278,960],"two":[280],"reasons:":[281],"CAN/IFTA":[282,291,314,335,706,1302],"deaths":[284],"with":[285,298,365,407,436,469,477,630,689,748,770,778,792,828,839,937,959,1013,1074,1079,1168,1173,1212,1273,1281,1322,1342,1521,1532],"functioning":[286,366],"grafts.":[287],"Pathologic":[288],"changes":[289],"(IFTA,":[292],"atherosclerosis,":[293],"glomerulosclerosis)":[295],"when":[296,871],"increasing":[299],"creatinine,":[300],"hypertension,":[301],"proteinuria":[303,764,780,794,814],"account":[304],"one":[306,504],"third":[307],"failures.":[310],"Risk":[311],"factors":[312,1434],"include":[315],"AR":[316,1101,1111],"within":[317],"1":[318],"year,":[319],"delayed":[320,863,1007],"function,":[322,865],"viral":[323,729],"therapy.":[327],"Cytomegalovirus":[328],"infection":[329],"implicated":[331],"development":[333,704,1303],"(via":[336],"enhanced":[337],"inflammation":[338],"augmented":[340],"immune":[341,415],"responses);":[342],"nephropathy":[343],"BK":[346,728],"virus":[347],"can":[348,1165,1398],"lead":[349],"loss.":[352],"Fifty":[353],"percent":[354],"losses":[358],"occur":[359],"death":[362],"recipients":[364,1359,1382],"grafts,":[367],"predominantly":[368],"CVD":[371,387,1402,1430],"de":[373,532,548,783,925,988,1014,1062,1357,1368],"novo":[374,533,784,926,935,989,1015,1358,1369],"malignancy.":[375],"Chronic":[376],"dysfunction":[378],"before":[379,510,703,1232],"risk":[384,429,1005,1099,1109,1433],"factor":[385],"development,":[388],"aggravated":[391],"exposure":[394,1040,1410],"(due":[395],"arteriolar":[397],"vasoconstriction":[398],"induced":[400],"diabetes).":[401],"therapy":[403,805,1049,1291,1397],"also":[405,755,850,1184,1563],"increased":[408,428,1012],"malignancy":[409,434],"(possibly":[410],"inhibition":[413,422],"surveillance,":[416],"induction":[417],"DNA":[419,424],"breaks,":[420],"repair":[425],"mechanisms).":[426],"CAN/IFTA,":[431],"CVD,":[432,527],"provides":[439],"rationale":[442,539],"reducing":[444,1038,1097],"exposure.":[446,463],"emphasizes":[448],"sirolimus":[453,480,567,631],"offer":[456,1085],"potential":[458,1032,1255],"help":[460],"reduce":[461,891,1399],"previous":[467],"studies":[468,1157],"elimination":[471,1083,1214,1231,1272,1326],"(6\u2013120":[474],"months":[475,1153],"posttransplant)":[476],"conversion":[478,771,844,1076,1117,1121,1137,1160,1306,1321,1341,1353,1372],"showed":[481,1158],"already":[484],"exhibiting":[485],"deterioration":[486,514],"function":[489,1009],"failed":[490],"improve.":[492],"Based":[493],"these":[495,742,882,1422,1511],"studies,":[496],"he":[497,517],"maintains":[498],"minimize":[501],"nephrotoxicity,":[503,1042],"should":[505,825,1562],"convert":[506],"signs":[511],"appear.":[515],"Finally,":[516],"briefly":[518],"mTORis":[524,581,776],"ameliorate":[526],"(viral)":[529],"malignancies,":[534],"providing":[535],"additional":[537,696,745,884,997,1254],"strategies.":[545],"Johan":[546,1060],"W.":[547,1061],"Fijter":[549,692],"\u0160tefan":[551,904],"V\u00edtko":[552,694,905],"mode":[555],"action":[557],"profile":[560],"(Section":[563,906],"2).":[564],"Everolimus":[565],"inhibit":[568,602],"interleukin-2-stimulated":[570],"T-cell":[571],"proliferation":[572,586],"pathway,":[573],"mTOR":[576],"central":[579],"component.":[580],"block":[582],"growth":[584],"factor-driven":[585],"both":[588,662],"hematopoietic":[589],"nonhematopoietic":[591],"cells,":[592],"including":[593,763],"vascular":[594],"bronchial":[596],"smooth":[597],"muscle":[598],"cells.":[599],"activation":[603],"p70S6":[605],"kinase":[606],"arrests":[608],"cell":[610],"cycle":[611],"G1":[614],"S":[616],"phase.":[617],"pharmokinetics":[619],"pharmacodynamics":[621],"described:":[625],"shorter":[627],"half-life":[628],"compared":[629],"(28":[632],"vs.":[633],"62":[634],"hr,":[635],"respectively)":[636],"means":[637],"no":[639,816,860],"loading":[640],"dose":[641,841,1284],"required,":[643],"it":[645],"reaches":[646],"steady":[648],"state":[649],"quickly":[651],"sirolimus.":[653],"Furthermore,":[654],"cyclosporine":[658],"(CsA)":[660],"metabolized":[663],"cytochrome":[666],"P450":[667],"isoenzyme":[668],"CYP3A":[669],"substrates":[672],"P-glycoproteins,":[674],"co-administration":[675],"CsA":[677,846,929],"increases":[678],"levels":[679],"everolimus;":[681],"however,":[682],"interaction":[684],"identified":[688],"tacrolimus.":[690,848],"De":[691,934],"provide":[695,756,908,1185,1480],"or":[707,802,843,847,868,878,1325,1371],"its":[709,1538],"stages":[711],"might":[712],"best":[713,1048],"preserve":[714],"function.":[716,962,1176],"They":[717,849,995,1017,1197,1219],"review":[718,1577,1583],"further":[719],"information":[720,1460],"incidence":[724,975],"cytomegalovirus":[726],"documented":[732],"activity,":[734],"probable":[737],"anti-CVD":[738,1415,1443],"suggest":[741],"significant":[744],"benefits":[746],"These":[753,1124,1262],"authors":[754,964,1125,1183],"management":[757],"mTORi-specific":[760],"adverse":[761],"events,":[762,867],"dyslipidemia.":[766],"Proteinuria":[767],"maintenance":[773],"rather":[781],"Conversion":[786],"advised":[789],"800":[797],"mg/dL;":[798],"angiotensin-converting":[799],"enzyme":[800],"inhibitors":[801],"angiotensin-receptor":[803],"blocker":[804],"may":[806,1045],"some":[808],"effectiveness":[809,1170],"treatment":[811],"mTORi-associated":[813],"(although":[815],"randomized":[817,855],"addressed":[821],"issue).":[823],"Dyslipidemia":[824],"be":[826,1046,1166,1564],"treated":[827],"statins":[829],"and,":[830,1043],"absence":[833],"suitable":[836],"response,":[837],"managed":[838],"reduction":[842],"point":[851],"out":[852],"multiclinical":[856],"show":[859,972,1001],"difference":[861],"wound-healing":[866,895,979],"3-month":[869],"tolerance":[870],"introduced":[874],"immediately":[875,1094],"after":[876,879,1107],"4":[880],"weeks;":[881],"other":[887],"cited":[888],"concerns":[892],"over":[893],"Bj\u00f6rn":[899,1239],"Nashan,":[900,1240],"Christophe":[901,1237],"Legendre,":[902,1238],"3)":[907],"detailed":[910],"summary":[911],"multiple":[914,968],"well-executed":[915],"setting":[927,990],"tacrolimus":[931,1285,1290],"minimization":[932,939,1028,1269,1324],"protocols.":[933],"at":[941,1146,1327],"least":[942],"standard":[946,1287,1294,1575],"CNI-based":[947],"regiments":[948],"terms":[950],"patient":[952],"cite":[965],"severity":[977],"complications":[980],"similar":[982],"used":[985,1142],"versus":[991,1270,1286,1338,1437],"MMF-based":[992],"regimens.":[994],"perceived":[1004],"strongly":[1018],"maintain":[1019],"strategy":[1029,1227],"outcomes":[1036],"therefore,":[1044],"low-":[1051],"moderate-risk":[1053],"patients.":[1054,1449],"Section":[1056,1246],"4,":[1057],"Hallvard":[1058,1242],"Holdaas,":[1059],"Fijter,":[1063],"examine":[1068],"experience":[1070],"elimination.":[1081],"advantages":[1086],"using":[1088],"deliver":[1091],"posttransplant,":[1095],"thereby":[1096],"then":[1103],"eliminating":[1104],"nephrotoxicity":[1106],"reduced.":[1113],"Studies":[1114],"employed":[1119],"(<6":[1122],"months).":[1123],"describe":[1126],"three":[1127,1156],"separate":[1128],"evaluating":[1132],"various":[1144],"7":[1147],"weeks,":[1148],"4.5":[1149],"months,":[1150],"6":[1152],"posttransplant.":[1154],"All":[1155],"instituted":[1167],"maintained":[1174],"Obviously,":[1177],"results":[1179,1502,1507],"awaited.":[1181],"excellent":[1187],"discussion":[1188],"selection":[1190],"conversion.":[1196],"table":[1201],"containing":[1202],"case":[1203],"histories":[1204],"illustrate":[1206],"specific":[1216],"situations.":[1218],"conclude":[1220],"substitution":[1223],"feasible":[1226],"facilitate":[1229],"irreversible":[1233],"occurs.":[1236],"Holdaas":[1243],"5":[1247],"explore":[1253],"roles":[1256],"transplantation.":[1261],"analyze":[1264],"protocols;":[1275],"comparative":[1277],"very":[1282],"low":[1283],"MMF":[1288],"(the":[1292],"so-called":[1293],"USFDA":[1295],"protocol);":[1297],"impact":[1300,1335],"(>12":[1311],"months),":[1312],"while":[1313],"another":[1314],"will":[1315],"compare":[1316],"effect":[1318,1444],"3":[1328],"months.":[1329],"Other":[1330],"investigating":[1333],"abrupt":[1337],"tapered":[1339],"elimination/minimization;":[1344],"efficacy,":[1346],"safety,":[1347],"tolerability":[1349],"older":[1360,1383,1391],"65":[1362],"years;":[1363],"efficacy/safety":[1366],"1-month":[1377],"posttransplant":[1378],"60":[1385],"years":[1386],"who":[1387],"receive":[1388],"transplants":[1389],"donors":[1392],"(>60":[1393],"years).":[1394],"Because":[1395],"CNI-associated":[1401],"facilitating":[1407],"direct":[1414],"drugs,":[1419],"many":[1420,1509],"incorporate":[1426],"analysis":[1428],"events":[1431],"everolimus-":[1436],"CNI-treated":[1438],"groups":[1439],"identify":[1441,1484],"any":[1442],"Transplantation":[1453],"feel":[1454],"contains":[1458],"our":[1462],"readers.":[1463],"It":[1464,1561],"essentially":[1465],"identifies":[1466],"all":[1467],"industry-sponsored,":[1470],"completed,":[1471],"involving":[1476],"substantial":[1481],"optimal":[1485],"utilization":[1489],"designed":[1492],"enhance":[1494],"Although":[1497],"short-":[1499],"moderate-term":[1501],"encouraging,":[1504],"(alluded":[1513],"throughout":[1515],"report)":[1517],"obviously":[1519],"awaited":[1520],"great":[1522],"interest.":[1523],"affirm":[1526],"produced":[1531],"organizational":[1533],"financial":[1535],"support":[1536],"sponsor":[1539,1587],"Novartis.":[1540],"endeavored":[1544],"ensure":[1546],"material":[1549,1568],"presented":[1550],"inappropriately":[1553],"biased":[1554],"interest":[1557],"sponsor.":[1560],"understood":[1565],"contained":[1569],"subjected":[1573],"peer":[1576,1582],"but":[1578],"internal":[1581],"organized":[1584],"Special":[1590],"Features":[1591],"Editors.":[1592]},"counts_by_year":[{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}